Dermalogica Inc -v- Nall [2003] DRS 1211 (27 October 2003)
The respondent registered the domain name primarily for the purpose of selling it to the complainants for valuable consideration in excess of out-of-pocket costs, which constitutes abusive registration under the Nominet DRS Policy. The domain name is similar to the complainants' mark, and the registration was unfairly detrimental to the complainants' rights.
- Citation
- [2003] DRS 1211
- Parties
- Complainants: Dermalogica Inc and International Dermal Institute Inc; Respondent: Christopher Nall
- Jurisdiction
- United Kingdom
- Judgment Date
- 27 October 2003
- Procedural Posture
- Domain Name Dispute (nominet Drs) / Decision of Independent Expert
- Outcome
- Complaint upheld; domain name to be transferred to complainants.
- Legal Topics
- Trade Marks, Domain Name Disputes, Abusive Registration, Cybersquatting
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Dermalogica Inc and International Dermal Institute Inc
Complainants
Christopher Nall
Respondent
Procedural Posture
Domain Name Dispute (nominet Drs) / Decision of Independent Expert
Legal Issues
- 1 Whether the complainants have rights in a name or mark similar to the domain name
- 2 Whether the domain name in the hands of the respondent is an abusive registration
Ratio Decidendi
The respondent registered the domain name primarily for the purpose of selling it to the complainants for valuable consideration in excess of out-of-pocket costs, which constitutes abusive registration under the Nominet DRS Policy. The domain name is similar to the complainants' mark, and the registration was unfairly detrimental to the complainants' rights.
Court Disposition
Complaint upheld; domain name to be transferred to complainants.
Orders
- The domain name dermalogicamailorder.co.uk is to be transferred to the complainants.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment